COVID-19 kills people with diabetes at roughly 2.5 times the rate of people without it, according to a 2025 meta-analysis of over one million patients. The reason isn’t a single vulnerability but a collision of problems: diabetes gives the virus more ways in, more fuel to replicate, a weakened immune defense to fight against, and a cardiovascular system already primed for the kind of clotting and inflammation that makes COVID-19 fatal.
The Virus Gets an Easier Entry Point
SARS-CoV-2 enters human cells by latching onto a protein called ACE2 on the cell surface. Think of ACE2 as a door handle the virus grabs to pull itself inside. In people with type 2 diabetes, the lungs have significantly more of these handles available. A study examining lung tissue found that ACE2 protein levels were elevated in both the air sacs (alveoli) and the airways (bronchial passages) of patients with diabetes compared to those without, even after accounting for smoking, obesity, lung disease, and medication use. More ACE2 on the surface of lung cells likely means more opportunities for the virus to infect those cells on initial exposure.
High Blood Sugar Fuels Viral Replication
Once the virus is inside, elevated glucose in the bloodstream actively helps it multiply. Research published in Cell Metabolism showed that glucose increased viral load, ACE2 expression, and inflammatory signaling inside infected immune cells called monocytes in a dose-dependent way. In plain terms: the higher the blood sugar, the more virus those cells produced and the more inflammation they triggered. This creates a vicious feedback loop where the infection itself can worsen blood sugar control, which in turn feeds more viral replication.
The Immune System Fights With One Hand Tied
Diabetes doesn’t just help the virus. It simultaneously hobbles the body’s ability to fight back. Chronic high blood sugar impairs nearly every branch of the immune response. Neutrophils, the first-responder white blood cells that rush to an infection site, lose their ability to navigate toward threats efficiently. Cells that are supposed to engulf and destroy pathogens (phagocytes) work less effectively. T cells, which are critical for identifying and killing virus-infected cells, mount a weaker response.
The result is that the virus replicates faster in the lungs while the immune system clears it more slowly. That delay gives the infection more time to spread deeper into lung tissue and, eventually, into the bloodstream.
Inflammation Spirals Out of Control
COVID-19’s most dangerous phase isn’t the viral infection itself. It’s the body’s inflammatory overreaction to it. In severe cases, the immune system floods the body with inflammatory molecules (cytokines) in a response sometimes called a cytokine storm. Diabetes sets the stage for this by keeping the immune system in a state of low-grade chronic inflammation even before infection. When COVID-19 arrives, the inflammatory response starts from a higher baseline and escalates faster.
The virus also consumes ACE2 as it enters cells, which disrupts the normal regulation of a hormone called angiotensin II. With less ACE2 available to break it down, angiotensin II builds up locally, causing blood vessels to constrict and triggering more inflammatory signaling. This damages the thin lining of blood vessels (the endothelium) in the lungs and can spread to blood vessels throughout the body.
Blood Vessels Already Damaged by Diabetes Take a Second Hit
This is where diabetes becomes especially dangerous. The disease doesn’t just affect blood sugar. It’s fundamentally a disease of blood vessels. Over one-third of people newly diagnosed with type 2 diabetes already have detectable damage to small blood vessels, visible as early kidney disease or changes in the retina. That damage extends throughout the body, including the lungs.
Healthy endothelial cells regulate blood clotting, control inflammation, and keep blood vessels relaxed. In diabetes, these cells are already dysfunctional: they’re less effective at preventing clots, less responsive to signals that dilate blood vessels, and less able to keep inflammatory cells from sticking to vessel walls. When COVID-19 then attacks these same endothelial cells directly (the virus enters them through ACE2, which is abundant on blood vessel surfaces), it’s hitting a system with no reserve capacity. Researchers have described this as pre-existing endothelial dysfunction meeting COVID-19’s “endotheliitis,” a combination that can rapidly progress to organ failure.
Blood Clots Become a Fatal Complication
The damaged, inflamed blood vessels in severe COVID-19 trigger widespread clotting, particularly in the tiny vessels of the lungs. These microclots block oxygen exchange and can spread to other organs. People with diabetes are especially prone to this complication because their clotting system is already shifted toward forming clots more readily.
Clinicians track a blood marker called D-dimer to gauge how much clotting is happening in the body. In one study of hospitalized COVID-19 patients, a D-dimer level above 2,885 ng/mL predicted death in diabetic patients with about 71% accuracy. That threshold reflects the degree to which clotting can overwhelm the body when diabetes and COVID-19 overlap.
Type 1 and Type 2 Carry Different Risks
Both types of diabetes increase the danger from COVID-19, but the risk profile differs. On the surface, people with type 2 diabetes appear to die at higher rates. However, type 2 diabetes is far more common in older adults who also tend to have obesity, hypertension, and other conditions that independently raise COVID-19 risk. When researchers adjusted for age, sex, and pre-existing vascular complications, one large analysis found that people with type 1 diabetes actually had a threefold greater risk of ICU admission and death compared to those with type 2.
This may reflect the distinct immune disruption in type 1 diabetes, where the immune system has already gone awry by attacking the body’s own insulin-producing cells. It may also relate to the greater difficulty of managing blood sugar during acute illness when someone depends entirely on external insulin.
Blood Sugar Control Before Infection Matters, but It’s Not the Whole Story
You might expect that people with well-controlled diabetes (reflected in a lower HbA1c, a measure of average blood sugar over three months) would fare much better. The picture is more complicated. While an HbA1c of 9% or above has been linked to higher hospitalization risk, at least one retrospective study found that once patients were already hospitalized with COVID-19, their HbA1c levels didn’t clearly predict who would survive and who wouldn’t.
This suggests that while chronic blood sugar control influences how likely you are to end up in the hospital, once severe COVID-19 takes hold, the accumulated vascular damage, immune dysfunction, and acute blood sugar swings during illness may matter more than your pre-infection average. In other words, diabetes reshapes the body in ways that a single lab number can’t fully capture, and those deeper changes are what make COVID-19 so much more dangerous.